Welcome to LookChem.com Sign In|Join Free

CAS

  • or

180535-58-4

Post Buying Request

180535-58-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

180535-58-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 180535-58-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,0,5,3 and 5 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 180535-58:
(8*1)+(7*8)+(6*0)+(5*5)+(4*3)+(3*5)+(2*5)+(1*8)=134
134 % 10 = 4
So 180535-58-4 is a valid CAS Registry Number.

180535-58-4Relevant articles and documents

Synthesis of Sulfonyl Fluorides from Sulfonamides

Pérez-Palau, Marina,Cornella, Josep

, p. 2497 - 2500 (2020)

A simple and practical synthesis of sulfonyl fluorides from sulfonamides is reported. The method capitalizes on the formation of the sulfonyl chloride by virtue of the reaction of Pyry-BF4 and MgCl2, and subsequent in situ conversion to the more robust and stable sulfonyl fluoride by the presence of KF. The mild conditions and high chemoselectivity of the protocol enable the late-stage formation of sulfonyl fluorides from densely functionalized molecules.

Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis

Pacchiano, Fabio,Carta, Fabrizio,McDonald, Paul C.,Lou, Yuanmei,Vullo, Daniela,Scozzafava, Andrea,Dedhar, Shoukat,Supuran, Claudiu T.

supporting information; experimental part, p. 1896 - 1902 (2011/05/17)

A series of ureido-substituted benzenesulfonamides was prepared that showed a very interesting profile for the inhibition of several human carbonic anhydrases (hCAs, EC 4.2.1.1), such as hCAs I and II (cytosolic isoforms) and hCAs IX and XII (transmembrane, tumor-associated enzymes). Excellent inhibition of all these isoforms has been observed with various members of the series, depending on the substitution pattern of the urea moiety. Several low nanomolar CA IX/XII inhibitors also showing good selectivity for the transmembrane over the cytosolic isoforms have been discovered. One of them, 4-{[(3′- nirophenyl)carbamoyl]amino}benzenesulfonamide, significantly inhibited the formation of metastases by the highly aggressive 4T1 mammary tumor cells at pharmacologic concentrations of 45 mg/kg, constituting an interesting candidate for the development of conceptually novel antimetastatic drugs.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 180535-58-4